Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 114,705

Sort by:

Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor-Pipeline Intelligence, 2019”, report ... by identifying potential partners with progressing projects for Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor to enhance and ...

December 2018 60 pages

Inhibitor of Apoptosis (IAP) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Inhibitor of Apoptosis (IAP) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Inhibitor of Apoptosis (IAP) Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Insulin Like Growth Factor (IGF) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Insulin Like Growth Factor (IGF) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Insulin Like Growth Factor (IGF) Inhibitor to enhance and expand business potential ...

December 2018 60 pages

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Intelligence, 2019

US$ 1,000.00

... delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Insulin Like Growth Factor 1 (IGF-1) Activators-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Insulin Like Growth Factor 1 (IGF-1) Activators to enhance and expand ...

December 2018 60 pages

Integrase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Integrase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Integrase Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor-Pipeline Intelligence, 2019”, report provides ... identifying potential partners with progressing projects for Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor to enhance and expand ...

December 2018 60 pages

interleukin Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “interleukin Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the interleukin Agonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-1 (IL-1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-1 (IL-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-1 (IL-1) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-10 (IL-10) Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Interleukin-10 (IL-10) Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Interleukin-12 (IL-12) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-12 (IL-12) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-12 (IL-12) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-13 (IL-13) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-13 (IL-13) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-13 (IL-13) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-17 (IL-17) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-17 (IL-17) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-17 (IL-17) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-18 (IL-18) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-18 (IL-18) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-18 (IL-18) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-2 (IL-2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-2 (IL-2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-2 (IL-2) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-2 (IL-2) Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Interleukin-2 (IL-2) Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Interleukin-23 (IL-23) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-23 (IL-23) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Interleukin-23 (IL-23) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-4 (IL-4) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-4 (IL-4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-4 (IL-4) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-5 (IL-5) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-5 (IL-5) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-5 (IL-5) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Interleukin-8 (IL-8) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Interleukin-8 (IL-8) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Interleukin-8 (IL-8) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Ionotropic Glutamate Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Ionotropic Glutamate Receptor Antagonist. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Isocitrate Dehydrogenase (IDH1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Isocitrate Dehydrogenase (IDH1) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Janus Kinase (JAK) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Janus Kinase (JAK) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Janus Kinase (JAK) Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Janus Kinase 1 (JAK1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Janus Kinase 1 (JAK1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Janus Kinase 1 (JAK1) Inhibitor R&D Please note: Certain sections in the report ...

December 2018 60 pages

Janus Kinase 3 (JAK3) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Janus Kinase 3 (JAK3) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Janus Kinase 3 (JAK3) Inhibitor R&D Please note: Certain sections in the report ...

December 2018 60 pages

Kainate Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Kainate Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Kainate Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Kallikrein Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Kallikrein Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Kallikrein Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Kappa Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Kappa Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Kappa Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Kv1.3/1.5 Potassium Channel Blockers -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Kv1.3/1.5 Potassium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Kv1.3/1.5 Potassium Channel Blockers. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Kv1.3 Potassium Channel Blockers -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Kv1.3 Potassium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Kv1.3 Potassium Channel Blockers. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

LAG-3 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “LAG-3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the LAG-3 Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Leukotriene Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Leukotriene Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Leukotriene Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Leukotriene D4 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Leukotriene D4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Leukotriene D4 Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Lipoxygenase Inhibitor (LOX Inhibitor) -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Lipoxygenase Inhibitor (LOX Inhibitor). Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor -Pipeline Intelligence, 2019”, report provides ... identifying potential partners with progressing projects for Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor to enhance and expand ...

December 2018 60 pages

Lysine Specific Demethylase 1 (LSD-1) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Lysine Specific Demethylase 1 (LSD-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Lysine Specific Demethylase 1 (LSD-1) Inhibitor to enhance and expand business ...

December 2018 60 pages

Matrix Metalloproteinase (MMP) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Matrix Metalloproteinase (MMP) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor-Pipeline Intelligence, 2019 ... identifying potential partners with progressing projects for Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor to ...

December 2018 60 pages

Matrix Metalloproteinase 9 (MMP-9) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Matrix Metalloproteinase 9 (MMP-9) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Matrix Metalloproteinase 9 (MMP-9) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Melanocortin 4 Receptor (MC4R) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Melanocortin 4 Receptor (MC4R) Agonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Metabotropic Glutamate Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Metabotropic Glutamate Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Methionine Aminopeptidase 2 (Metap2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Methionine Aminopeptidase 2 (Metap2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Methionine Aminopeptidase 2 (Metap2) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

mGlu 2/3 Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the mGlu 2/3 Agonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

mGlu 2/3/5 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3/5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the mGlu 2/3/5 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

mGlu5 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “mGlu5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mGlu5 Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Mitochondrial Electron Transport Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Mitochondrial Electron Transport Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor-Pipeline Intelligence, 2019”, report ... by identifying potential partners with progressing projects for Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor to enhance and ...

December 2018 60 pages

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor-Pipeline Intelligence, 2019”, ... by identifying potential partners with progressing projects for Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor to ...

December 2018 60 pages

Monoamine Oxidase Inhibitor (MAOIs) -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Monoamine Oxidase Inhibitor (MAOIs)-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Monoamine Oxidase Inhibitor (MAOIs). Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Monoamine Oxidase B (MAO-B) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Monoamine Oxidase B (MAO-B) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Monoamine Oxidase B (MAO-B) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

Filters

Clear all